Skip to main content
Cancer Explained
Donate

NewsTrending topic

England introduces standardized (plain) tobacco packaging

England introduces standardized (plain) tobacco packaging (United Kingdom, 2016). What changed, who is affected, and what it does and doesn't mean.

By Cancer Explained Editorial TeamPublished Updated

Original commentary from the Cancer Explained editorial team.

A woman presses a beige nicotine patch onto her bare upper arm
Applying the Patch — illustrative photograph, not of anyone named in this story.

Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.

The law that made every pack look the same

The Standardised Packaging of Tobacco Products Regulations 2015 came into force on 20 May 2016. They apply across the United Kingdom.

The rules are unusually specific. The outside of a cigarette pack may be one colour only: Pantone 448 C, with a matt finish. That is a dull brown-green. Inside, only white or the same Pantone 448 C is allowed.

Packs must be cuboid, made of carton or soft material, with edges that may be bevelled or rounded. If a pack re-closes, it may only do so with a flip-top lid or a shoulder-box hinged lid. A flip-top may hinge only at the back.

A pack must hold at least 20 cigarettes. Hand-rolling tobacco must come in units of at least 30 grams. Larger packs cost more in one go, and the rule removes the cheap small pack.

Even the cigarette itself is regulated. Paper, casing, and filter must be plain white and matt, except that the unlit end may imitate cork. Any brand text on a cigarette must be Helvetica, black, regular weight, no larger than 8 point.

What the law forbids

Regulation 10 bans packaging elements that suggest a product is less harmful, has rejuvenating, natural, or organic properties, or brings other health or lifestyle benefits. It bans references to taste, smell, flavorings, or the absence of them. It bans packs that resemble food or cosmetics, and claims of better biodegradability.

Regulation 10 also bans anything suggesting economic advantage. No printed vouchers, no discounts, no free distribution, no two-for-one offers.

Regulation 11 bans packaging that makes a noise or carries a scent. Regulation 12 bans features that change after sale: heat-activated inks, inks that appear over time, fluorescent inks, scratch-off panels, removable tabs, and fold-out panels.

The transitional rule gave the trade a year. Stock made before 20 May 2016 could still be supplied until 21 May 2017.

What the evidence actually says

A Cochrane review published in April 2017 examined 51 studies involving roughly 800,000 participants. Australia was the only country that had implemented standardized packaging in time to be evaluated.

One Australian observational study of 700,000 people found a 3.7 percent reduction in the odds of smoking, or about a 0.5 percentage point drop in smoking prevalence, after adjusting for confounders. Cochrane rated confidence in that finding as low by GRADE standards.

Findings on how much people smoked were mixed, and rated very low certainty. One Australian cohort study of 5,441 smokers found quit attempts rose from 20.2 percent before the change to 26.6 percent a year after. Calls to quitlines rose by 78 percent.

The clearer results were about appeal. Standardized packs consistently rated lower than branded packs. Tobacco in them was generally judged worse-tasting and lower quality. Eye-tracking studies showed people looked at the health warnings more.

The reviewers found no evidence that standardized packaging increases tobacco use.

Why any of this matters medically

NCI states that tobacco smoke contains more than 7,000 chemicals. At least 250 are known to be harmful, and at least 69 of those can cause cancer. The list includes arsenic, benzene, cadmium, formaldehyde, and polonium-210.

Smoking causes cancers of the lung, esophagus, larynx, mouth, throat, kidney, bladder, liver, pancreas, stomach, cervix, colon, and rectum. It also causes acute myeloid leukemia, a cancer of the blood.

NCI calls smoking the leading cause of premature, preventable death in the United States, responsible for about 480,000 premature deaths a year. About 36 percent of those are from cancer. Death rates among smokers run about three times those of people who never smoked.

The American Cancer Society projects 229,410 new lung and bronchus cancers in the United States in 2026 and 124,990 deaths — 20.0 percent of all cancer deaths — and SEER reprints those numbers. Our page on lung cancer covers how the disease is grouped and treated.

Quitting changes the arithmetic

NCI's figures are worth stating precisely, because they are more encouraging than most people expect.

Smokers who quit before age 40 cut their chance of dying early from smoking-related disease by about 90 percent. Those who quit between 45 and 54 cut it by about two-thirds.

On life expectancy, people who quit between ages 25 and 34 live about 10 years longer than those who keep smoking. Quitting between 35 and 44 adds about 9 years. Between 45 and 54, about 6 years. Between 55 and 64, about 4 years.

The short-term changes start fast. Carbon monoxide in the blood begins to fall within hours. Within a few weeks circulation improves, phlegm falls, and coughing and wheezing ease. Within several months lung function improves substantially.

When to get checked

The NHS says a cough that has not gone after 3 weeks should be seen by a doctor. That is a concrete threshold, and it is the one worth remembering. The NHS also lists:

  • A long-standing cough that gets worse
  • Chest infections that keep coming back
  • Coughing up blood
  • An ache or pain when breathing or coughing
  • Persistent breathlessness
  • Persistent tiredness or lack of energy
  • Loss of appetite, or unexplained weight loss

Less common signs include finger clubbing, where fingertips become curved or enlarged, difficulty swallowing, wheezing, a hoarse voice, and swelling of the face or neck.

Screening is a separate track. Our page on lung cancer screening explains who is eligible and why the rules use smoking history rather than symptoms.

What this does and doesn't change

Standardized packaging is a population measure. It does not treat anyone, diagnose anyone, or change anyone's care.

The size of its effect is genuinely uncertain. The one prevalence estimate available came from a single observational study in a different country, and Cochrane rated it low certainty. Plain packs also arrived in the UK alongside the EU Tobacco Products Directive's larger combined health warnings, so the two changes are hard to separate.

Tobacco control works as a stack, not as one intervention. Price, advertising bans, smoke-free laws, warning labels, and cessation support all act at once. Our page on cancer risk factors puts smoking beside the other causes.

And rules change. Anyone checking what applies where they live should read the current official text rather than a summary of it.

Sources

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Put the story in context

Prevention, possible warning signs, screening, and diagnosis

This story relates to Lung cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.

  • Prevention and risk reduction

    Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.

    NCI prevention information

  • Symptoms and possible early signs

    Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.

    NCI signs and symptoms

  • Screening and early detection

    Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.

    NCI cancer screening information

  • How cancer is diagnosed

    Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.

    NCI diagnosis information

A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.

Go deeper with NCI